Ambalal Sarabhai Enterprises Share Price

  • 46.92-1.11 (-2.31%)
  • Volume: 1,33,645
BSE
  • Live
  • Last Updated On: 02 Jul, 2024, 12:56 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Ambalal Sarabhai Enterp...

  • 46.92-1.11 (-2.31%)
  • Volume: 1,33,645
Advertisment

Ambalal Sarabhai share price insights

View All

  • Company has spent 2.16% of its operating revenues towards interest expenses and 15.96% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

  • Stock gave a 3 year return of -1.17% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

  • Stock generated -1.17% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

  • Ambalal Sarabhai Enterprises Ltd. share price moved down by -0.47% from its previous close of Rs 48.03. Ambalal Sarabhai Enterprises Ltd. stock last traded price is 47.80

    Share PriceValue
    Today/Current/Last-47.80
    Previous Day-48.03

InsightsAmbalal Sarabhai

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		56.09
    EPS - TTM
    (₹)    		0.84
    MCap
    (₹ Cr.)    		360.18
    Sectoral MCap Rank
    		95
    PB Ratio
    (x)    		2.68
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month-0.09
    3 Months0.00
    6 Months0.36
    1 Year0.81
    3 Years1.08

    		-0.09
    VWAP
    (₹)    		47.53
    52W H/L
    (₹)
    70.00 / 26.05

    Ambalal Sarabhai Share Price Returns

    1 Day-2.31%
    1 Week-1.53%
    1 Month-1.66%
    3 Months-10.25%
    1 Year62.97%
    3 Years39.44%
    5 Years247.56%

    ET Stock ScreenersTop Score Companies

    Check whether Ambalal Sarabhai belongs to analysts' top-rated companies list?

    View Stock Screeners

    Ambalal Sarabhai News & Analysis

    View all Ambalal Sarabhai Share News & Announcements

    Ambalal Sarabhai Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Ambalal Sarabhai Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Ambalal Sarabhai Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Employee & Interest Expense

        Company has spent 2.16% of its operating revenues towards interest expenses and 15.96% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income59.1344.4742.8637.4748.80
      Total Income Growth (%)32.973.7514.39-23.2127.00
      Total Expenses48.8741.7240.0940.1542.01
      Total Expenses Growth (%)17.154.04-0.13-4.4323.27
      EBIT10.272.762.77-2.676.79
      EBIT Growth (%)272.19-0.43--139.3756.23
      Profit after Tax (PAT)9.021.181.08-4.875.49
      PAT Growth (%)664.518.83--188.6882.71
      EBIT Margin (%)17.366.206.46-7.1313.92
      Net Profit Margin (%)15.252.652.53-13.0011.25
      Basic EPS (₹)1.180.150.15-0.640.72
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income4.411.652.762.883.72
      Total Income Growth (%)166.61-40.15-4.30-22.35-7.22
      Total Expenses1.681.982.164.882.44
      Total Expenses Growth (%)-15.37-8.14-55.84100.283.00
      EBIT2.73-0.330.60-2.001.28
      EBIT Growth (%)--154.33--256.43-22.00
      Profit after Tax (PAT)4.70-0.650.56-2.021.12
      PAT Growth (%)--216.13--281.24-30.99
      EBIT Margin (%)61.95-19.8721.89-69.2634.38
      Net Profit Margin (%)106.62-39.3920.30-70.1530.05
      Basic EPS (₹)0.62-0.080.07-0.260.15
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue183.95182.77238.76194.22157.89
      Total Revenue Growth (%)0.64-23.4522.9323.010.34
      Total Expenses174.58166.91175.87170.79141.58
      Total Expenses Growth (%)4.60-5.102.9720.64-6.48
      Profit after Tax (PAT)5.6811.1047.2229.3614.06
      PAT Growth (%)-48.82-76.4960.85108.76230.92
      Operating Profit Margin (%)7.5510.7432.8216.1114.70
      Net Profit Margin (%)3.276.5123.9917.9310.53
      Basic EPS (₹)0.741.456.163.831.83
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue11.7014.2439.6629.6124.61
      Total Revenue Growth (%)-17.82-64.1033.9420.33280.80
      Total Expenses10.899.126.1339.088.71
      Total Expenses Growth (%)19.4548.61-84.30348.91-11.95
      Profit after Tax (PAT)2.584.112.96-9.3915.55
      PAT Growth (%)-37.1639.06--160.37-
      Operating Profit Margin (%)26.42141.120.000.000.00
      Net Profit Margin (%)67.79110.892,318.500.000.00
      Basic EPS (₹)0.340.540.39-1.222.03

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets250.23245.74230.50210.05186.45
      Total Assets Growth (%)1.826.619.7412.66-14.20
      Total Liabilities113.09114.82110.65136.16141.69
      Total Liabilities Growth (%)-1.503.77-18.74-3.90-24.10
      Total Equity137.14130.93119.8673.8944.76
      Total Equity Growth (%)4.749.2462.2165.0846.19
      Current Ratio (x)1.161.231.140.940.78
      Total Debt to Equity (x)0.330.310.210.350.63
      Contingent Liabilities29.2432.3535.2443.8253.25
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets81.2879.7482.99100.05124.60
      Total Assets Growth (%)1.93-3.92-17.05-19.70-10.12
      Total Liabilities40.9941.9049.2969.2684.35
      Total Liabilities Growth (%)-2.17-14.99-28.83-17.89-25.91
      Total Equity40.2937.8533.7030.7940.25
      Total Equity Growth (%)6.4512.319.45-23.5062.43
      Current Ratio (x)0.900.960.880.720.53
      Total Debt to Equity (x)0.250.220.290.360.27
      Contingent Liabilities50.4950.4243.1246.9457.30

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 1.13 cr for investing activities which is an YoY decrease of 93.29%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities4.725.7211.47-2.30-6.88
      Net Cash used in Investing Activities-1.13-16.785.0810.0916.89
      Net Cash flow from Financing Activities-2.959.09-19.19-5.84-14.22
      Net Cash Flow0.65-1.97-2.641.95-4.21
      Closing Cash & Cash Equivalent10.7810.1312.1014.7412.79
      Closing Cash & Cash Equivalent Growth (%)6.38-16.29-17.8915.26-24.76
      Total Debt/ CFO (x)9.567.012.23-11.28-4.10
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities-3.821.70-7.79-10.42-4.53
      Net Cash used in Investing Activities3.480.4320.7715.764.92
      Net Cash flow from Financing Activities0.30-3.76-16.46-0.32-0.42
      Net Cash Flow-0.04-1.63-3.475.02-0.03
      Closing Cash & Cash Equivalent0.130.171.805.270.25
      Closing Cash & Cash Equivalent Growth (%)-24.82-90.74-65.892,021.62-11.79
      Total Debt/ CFO (x)-2.634.84-1.25-1.07-2.43

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)4.148.4739.3939.7231.41
      Return on Capital Employed (%)8.8612.1551.6532.3637.05
      Return on Assets (%)2.274.5120.4813.977.54
      Interest Coverage Ratio (x)4.448.6439.349.765.91
      Asset Turnover Ratio (x)0.700.720.00-71.60
      Price to Earnings (x)61.7314.185.674.6110.40
      Price to Book (x)2.541.202.231.833.26
      EV/EBITDA (x)21.618.043.964.516.88
      EBITDA Margin (%)9.6112.3634.0017.5916.62
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)6.4110.868.77-30.4938.63
      Return on Capital Employed (%)2.4713.6797.71-27.6038.63
      Return on Assets (%)3.175.153.56-9.3812.48
      Interest Coverage Ratio (x)5.8350.43137.52-15.9835.22
      Asset Turnover Ratio (x)0.050.050.000.000.00
      Price to Earnings (x)135.1438.3190.91-14.439.39
      Price to Book (x)8.654.157.944.393.63
      EV/EBITDA (x)316.7130.128.01-16.169.10
      EBITDA Margin (%)29.46145.030.000.000.00

    Financial InsightsAmbalal Sarabhai

    • Income (P&L)
    • Cash Flow

      • Employee & Interest Expense

        Company has spent 2.16% of its operating revenues towards interest expenses and 15.96% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 1.13 cr for investing activities which is an YoY decrease of 93.29%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Ambalal Sarabhai Peer Comparison

    • Ambalal Sarabhai Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of -1.17% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated -1.17% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of -1.17% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated -1.17% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Ambalal Sarabhai56.182.634.148.862.27-1.787.554.830.741.160.339.56
          Venus Remedies17.030.995.848.174.542.567.434.7321.314.530.081.11
          Fredun Pharma26.143.3612.8626.365.0736.7210.054.4733.321.470.87-240.51
          Jenburkt Pharma14.952.6817.9223.8315.738.7924.9618.2958.866.700.000.00
          Lyka Labs-158.755.60-3.653.66-1.588.573.92-2.35-0.791.350.8432.36
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Zenotech Lab
          • Gennex Labs
          • Medico Remedies
          • Natural Capsule
          • SMS Lifesciences Ind

          Choose from Stocks

            See All Parameters

          Peers InsightsAmbalal Sarabhai

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of -1.17% as compared to Nifty Smallcap 100 which gave a return of 80.38%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated -1.17% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Ambalal Sarabhai Shareholding Pattern

          • QOQ Change

          • Total Shareholdings

          • Loading...
            Showing Ambalal Sarabhai Shareholding as on 31 Mar 2024
            Category31 Mar 202431 Dec 202330 Sep 202330 Jun 2023
            Promoters30.7730.7730.7730.77
            Pledge0.000.000.000.00
            FII0.000.000.000.00
            DII0.000.000.000.00
            Mutual Funds0.000.000.000.00
            Others69.2369.2369.2369.23
          • Showing Shareholding as on 31 Mar 2024
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters2,35,83,11630.77 %0.00
            Pledge00.00 %0.00
            DII4,4370.00 %0.00
            Others5,30,45,74369.23 %0.00

          MF Ownership

          MF Ownership details are not available.

          Top Searches:

          Ambalal Sarabhai News Ambalal Sarabhai Quarterly Results Ambalal Sarabhai Dividend Ambalal Sarabhai Q1 ResultsAmbalal Sarabhai Q2 ResultsAmbalal Sarabhai Q3 ResultsAmbalal Sarabhai Q4 Results

          Corporate Actions

          • Ambalal Sarabhai Board Meeting/AGM

          • Ambalal Sarabhai Dividends

          • Others

          • Board Meeting/AGM details are not available.

          • Dividend announcements are not available.

          • No other corporate actions details are available.

          About Ambalal Sarabhai

          Ambalal Sarabhai Enterprises Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 368.07 Crore) operating in Pharmaceuticals sector. Ambalal Sarabhai Enterprises Ltd. key Products/Revenue Segments include Pharmaceuticals for the year ending 31-Mar-2023. Show More

          • Executives

          • Auditors

          • KV

            Kartikeya V Sarabhai

            Executive Chairman
            MK

            Mohal K Sarabhai

            Managing Director
            CM

            Chaula M Shastri

            Whole Time Director
            AM

            Ajay Mayor

            Nominee Director
            Show More
          • Sorab S Engineer & Co.
            Khandhar & Asscociates

          Industry

          Pharma - Indian

          Key Indices Listed on

          -

          Address

          Shanti Sadan,Mirzapur Road,Ahmedabad, Gujarat - 380001

          Contact

          [email protected]

          http://www.ase.life

          More Details

          Trending in Markets

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Ambalal Sarabhai Share Price
          The Economic Times